A Second Opinion: Important for Pancreatic Cancer Patients
Facing a new reality of having one of the toughest-to-treat cancers can indeed be overwhelming. That’s why it’s so important…
New Guidelines on the Use of Radiation for Pancreatic Cancer Treatment
New clinical guidelines from the American Society for Radiation Oncology will help clarify the best uses of radiation treatment for pancreatic cancer.
Dousing Out-of-Control KRAS Signaling in Pancreatic Cancer
Rene Bernards and his team are targeting the signaling pathway of the KRAS mutation, which occurs in almost all pancreatic cancers.
Pancreatic Cancer: 2018 Highlights And Looking Forward to 2019
Dr. Allyson Ocean leads an overview of the new treatments and protocol from 2018 as well as what are the next steps in treatment for 2019.
Genetic Sequencing of Advanced Pancreatic Cancer Enables Personalized Medicine
Dr. Brian Wolpin has found that about 1/3 of pancreatic cancer patients may benefit from genetic sequencing to determine treatment.
Organoids Accurately Predict Treatment Response of Pancreatic Cancer Patients
An international team of researchers led by Dr. David Tuveson has found that organoids can predict how pancreatic cancer patients will respond to different treatments.
Lustgarten Foundation Appoints David Tuveson, M.D., Ph.D., Chief Scientist
Dr. David Tuveson has been appointed the chief scientist for the Lustgarten Foundation. He specializes in pancreatic cancer reseach at the Cold Spring Harbor Labs.
Let’s Win Launches Online Video Series Featuring Long-Term Pancreatic Cancer Survivors
Meet long-term survivors of pancreatic cancers, in our new Survivors Video Series. The introductory video was launched in January at a cancer symposium.
Let’s Win and Partners Present Poster and Abstract at Gastrointestinal Cancer Symposium
"Introduction of #PancChat: A novel Twitter platform to inform and engage the pancreatic cancer community" at the 2018 Gastrointestinal Cancers…
New CancerSEEK Test Greater than 99 Percent Specific for Pancreatic Cancer
Dr. Anne Marie Lennon and colleagues have developed a blood screening test that can detect early cancer in eight organs, including the pancreas.